HMR Pharma Inc.
Records under this name other than patents HMR Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,109,161 | Preserved pharmaceutical formulations Formerly held Term ended Term ended Oct 14, 2021 · From the USPTO record | Term ended | Term ended Oct 14, 2021 | From the USPTO record |
| US 7,754,678 | Membrane Penetrating Peptides and Uses Thereof Formerly held Term ended Term ended Aug 21, 2021 · High confidence | Term ended | Term ended Aug 21, 2021 | High confidence |
| US 6,576,647 | Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one Formerly held Term ended Term ended Jan 16, 2021 · From the USPTO record | Term ended | Term ended Jan 16, 2021 | From the USPTO record |
| US 6,229,014 | Spiro[cyclopent[b]indole-piperidines] Formerly held Term ended Term ended Jul 24, 2020 · From the USPTO record | Term ended | Term ended Jul 24, 2020 | From the USPTO record |
| US 6,716,986 | Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]ester Formerly held Term ended Term ended Jul 13, 2020 · From the USPTO record | Term ended | Term ended Jul 13, 2020 | From the USPTO record |
| US 6,512,125 | Preparation of 1H-indol-1-amines Formerly held Term ended Term ended Jan 28, 2020 · From the USPTO record | Term ended | Term ended Jan 28, 2020 | From the USPTO record |
| US 6,329,550 | Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase Formerly held Term ended Term ended Dec 17, 2019 · From the USPTO record | Term ended | Term ended Dec 17, 2019 | From the USPTO record |
| US 6,352,976 | Selective inhibitors of MMP-12 Formerly held Term ended Term ended Dec 17, 2019 · From the USPTO record | Term ended | Term ended Dec 17, 2019 | From the USPTO record |
| US 6,486,193 | 3-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases Formerly held Term ended Term ended Dec 17, 2019 · From the USPTO record | Term ended | Term ended Dec 17, 2019 | From the USPTO record |
| US 6,555,328 | Screening methods for altering circadian rhythms and for human casein kinase I &dgr; and/or &egr; phosphorylation of human clock proteins, period 1, -2 and -3 Formerly held Term ended Term ended Dec 14, 2019 · From the USPTO record | Term ended | Term ended Dec 14, 2019 | From the USPTO record |